Antitumor gold (III) complexes

Pharmacia

Volumn 52, Issue 1-2, 2005, Pages 64-67

  Messori, Luigi ^a   Orioli, P ^a   Gabbiani, C ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antineoplastic agents chemical synthesis, therapeutic use; Gold compounds chemical synthesis, therapeutic use; Organometalic compounds chemical synthesis, therapeutic use

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYTOTOXIC AGENT; GOLD COMPLEX; PLATINUM DERIVATIVE;

ABSORPTION SPECTROSCOPY; ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CYTOTOXICITY; DRUG DNA INTERACTION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; EVIDENCE BASED MEDICINE; HUMAN; PHYSICAL CHEMISTRY; POTENTIOMETRY; SHORT SURVEY;

EID: 21244432356     PISSN: 04280296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (18)

1. Abbate, F. et al. Crystal structure and solution chemistry of the cytotoxic complex 1,2-dichloro(o-phenanthroline)gold(III) chloride. - Inorg. Chim. Acta, 311, 2000, 1-5.
2. Buckley, R. G. et al. - J. Med. Chem., 39, 1996, 5208-5214.
3. Calamai, P.et al., Biological properties of two gold(III) complexes: AuCl3 (Hpm) and AuCl2 (pm). - J. Inorg. Biochem., 66, 1997, 103-109.
4. Calamai, P. et al. Cytotoxic effects of gold(III)complexes on established human tumor cell fines sensitive and resistano to cisplatin. - Anticancer Drug Design, 13, 1998, 67-80.
5. Calamai, P. et al., Structure and DNA binding properties of the gold(III) complex AuCl2(esal). - Inorg. Chim. Acta, 285, 1999, 309-312.
6. Carotti, S. et al. Gold(III) compounds as potential antitumor agents: Cytotoxicity and DNA binding properties of some selected polyaminegold(III) complexes. - Inorg. Chim. Acta, 281, 1998, 90-94.
7. Dar, A. et al., Complexes of gold(III) with mononegative bidentate N,O-ligands. - J. Chem. Soc., Dalton Trans., 12, 1992, 1907-1914.
8. Dhubhghaill, O. M. et P. J. Sadler. In: Metal Complexes in Cancer Chemotherapy, Weinheim, VCH, 1993, 221.
9. Lippert, B. In: Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug, New York John Wiley & Sons, 1999.
10. Marcon, G. et al. Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties. - J. Med. Chem., 45, 2002, 1672-1677.
11. Messori, L. et al., Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds. - J. Med. Chem., 43, 2000, 3541-3548.
12. Messori, L. et al., Interactions of selected gold(III) complexes with calf thymus DNA. - Biochem. Biophys. Res. Commun., 281, 2001, 352-360.
13. Parish, R.V. et al., Chemical and Biological Studies of Dichloro(2-((dimethylamino)methyl)phenyl)gold(III). - Inorg. Chem., 35, 1996, 1659-1666.
14. Puddephatt, R. J. - In: The Chemistry of Gold. Amsterdam, Elsevier, 1978.
15. Rosenberg, B. et al. Platinum compounds: a new class of potent antitumour agents. - Nature, 222, 1969, 385-386.
16. Sadler, P. J., M. Nasr et V. L. Narayanan. - In: Platinum Coordination Complexes in Cancer Chemotherapy. Boston, Martinus Nijhoff Publishing, 1984, 209.
17. Shaw III, C. F. Gold-Based Therapeutic Agents. - Chem. Rev., 99, 1999, 2589-2600.
18. Wong, E. et C. M. Giandomenico. Current status of platinum-based antitumor drugs. - Chem. Rev., 99, 1999, 2451-2466.